PapersFlow Research Brief
Health Promotion and Cardiovascular Prevention
Research Guide
What is Health Promotion and Cardiovascular Prevention?
Health Promotion and Cardiovascular Prevention is the cluster of research examining the effectiveness of general health check programs in preventive services, cardiovascular risk assessment, and population health to reduce chronic disease incidence.
This field includes 49,534 works focused on screening uptake, healthcare inequality, and risk factor detection in public health programs. The SF-36 survey, developed by Ware and Sherbourne (1992), assesses health status across eight concepts for use in clinical practice, research, and policy evaluations. Cardiovascular risk tools like the SCORE project by Conroy (2003) estimate ten-year fatal cardiovascular disease risk in Europe.
Topic Hierarchy
Research Sub-Topics
Cardiovascular Risk Assessment Tools
Develops and validates multivariable risk scores like SCORE, Framingham, and ASCVD calculators incorporating age, lipids, blood pressure, and diabetes status. Researchers improve predictive accuracy through machine learning and novel biomarkers.
Health Check Program Effectiveness
Conducts RCTs and meta-analyses evaluating general health check-ups' impact on cardiovascular events, mortality, and healthcare costs. Studies address screening yield, overdiagnosis, and behavioral change sustainability.
Primary Prevention Guidelines
Analyzes evolution of ACC/AHA and ESC guidelines for lifestyle, pharmacotherapy, and risk factor targets in asymptomatic populations. Researchers assess guideline concordance, implementation gaps, and outcome improvements.
Screening Uptake Determinants
Examines sociodemographic, psychological, and system-level barriers to cardiovascular screening participation using behavioral models. Interventions test nudges, incentives, and digital reminders to boost attendance.
Healthcare Inequality in Prevention
Quantifies disparities in cardiovascular risk detection and management by race, income, geography, and insurance status using cohort studies. Research evaluates equity-focused policies and culturally-tailored interventions.
Why It Matters
Health promotion and cardiovascular prevention guide public health programs that address healthcare inequality and improve screening uptake for chronic disease prevention. The 2019 ACC/AHA Guideline by Arnett et al. (2019) recommends team-based care and lifelong healthy lifestyles to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation, with clinicians evaluating social determinants. The SCORE project by Conroy (2003) provides direct estimation of total fatal cardiovascular risk suited to clinical practice constraints, enabling targeted primary prevention. The Global Burden of Disease Study by Forouzanfar et al. (2016) quantifies risks from 79 behavioral, environmental, occupational, and metabolic factors from 1990–2015, informing population-level interventions. The Cardiovascular Health Study by Fried et al. (1991) supports longitudinal assessment of risk factors in older adults.
Reading Guide
Where to Start
"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection." by Ware and Sherbourne (1992), as it provides the foundational health status measurement tool used across clinical and population studies in this field.
Key Papers Explained
Ware and Sherbourne (1992) in "The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection." and the related "The MOS 36-Item Short-Form Health Survey (SF-36)" establish SF-36 for health assessments, which Ware (1994) extends in "SF-36 physical and mental health summary scales: a user's manual." Fried et al. (1991) apply similar concepts in "The cardiovascular health study: Design and rationale" for cohort design. Conroy (2003) builds on risk detection in "Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project," while Arnett et al. (2019) integrate these into guidelines in "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary."
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research emphasizes team-based care and social determinant evaluation per Arnett et al. (2019), with ongoing focus on risk estimation like SCORE by Conroy (2003) for primary prevention. No recent preprints or news available, so frontiers remain in applying SF-36 and burden analyses from Forouzanfar et al. (2016) to screening uptake and inequality.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The MOS 36-item short-form health survey (SF-36). I. Conceptua... | 1992 | PubMed | 34.0K | ✕ |
| 2 | The MOS 36-ltem Short-Form Health Survey (SF-36) | 1992 | Medical Care | 29.0K | ✕ |
| 3 | Global, regional, and national comparative risk assessment of ... | 2016 | The Lancet | 7.7K | ✓ |
| 4 | Estimation of ten-year risk of fatal cardiovascular disease in... | 2003 | European Heart Journal | 5.2K | ✓ |
| 5 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovasc... | 2019 | Circulation | 4.5K | ✓ |
| 6 | SF-36 physical and mental health summary scales : a user's manual | 1994 | Medical Entomology and... | 4.2K | ✕ |
| 7 | The cardiovascular health study: Design and rationale | 1991 | Annals of Epidemiology | 3.6K | ✕ |
| 8 | Morbidity and Mortality Weekly Report | 2011 | Wilderness and Environ... | 3.4K | ✕ |
| 9 | What is an adequate sample size? Operationalising data saturat... | 2009 | Psychology and Health | 3.2K | ✕ |
| 10 | Park's Textbook Of Preventive And Social Medicine | 2021 | — | 3.0K | ✕ |
Frequently Asked Questions
What is the SF-36 in health promotion research?
The SF-36 is a 36-item short-form health survey constructed for the Medical Outcomes Study to assess health status across eight concepts. Ware and Sherbourne (1992) designed it for clinical practice, research, health policy evaluations, and general population surveys. "The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection" details its multi-item scales.
How does the SCORE project assess cardiovascular risk?
The SCORE risk estimation system offers direct estimation of total fatal cardiovascular risk in a format suited to clinical practice constraints. Conroy (2003) developed it for Europe based on ten-year risk data. "Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project" supports primary prevention efforts.
What are key recommendations in the 2019 ACC/AHA Guideline?
The guideline states that promoting a healthy lifestyle throughout life is the most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation. Arnett et al. (2019) advocate team-based care as an effective strategy, with evaluation of social determinants. "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary" outlines these for clinical practice.
What does the Global Burden of Disease Study 2015 cover?
The study provides a systematic analysis of 79 behavioural, environmental, occupational, and metabolic risks or clusters from 1990–2015 at global, regional, and national levels. Forouzanfar et al. (2016) quantify these for cardiovascular prevention insights. It informs public health programs on risk factor detection.
What is the focus of the Cardiovascular Health Study?
The study designs and rationalizes a cohort for assessing cardiovascular risk factors in older populations. Fried et al. (1991) established it to evaluate health promotion impacts. "The cardiovascular health study: Design and rationale" supports chronic disease prevention research.
Open Research Questions
- ? How can screening uptake be increased to address healthcare inequality in cardiovascular risk assessment?
- ? What factors most influence the effectiveness of general health check programs in population health?
- ? How do social determinants modify the impact of preventive services on chronic disease prevention?
- ? Which combinations of behavioral and metabolic risks yield the highest population-attributable fractions for fatal cardiovascular events?
Recent Trends
The field encompasses 49,534 works with no specified 5-year growth rate.
Persistent emphasis on SF-36 by Ware and Sherbourne with 33,978 and 29,049 citations respectively underscores health measurement standards.
1992Guidelines like Arnett et al. with 4,485 citations reflect current primary prevention focus, but no recent preprints or news indicate steady rather than accelerating activity.
2019Research Health Promotion and Cardiovascular Prevention with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Health Promotion and Cardiovascular Prevention with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers